LONIAL SAGAR sold 27.1% of their position (34.85K shares) of TG THERAPEUTICS, INC. on the open market
Open‑market sale worth $814.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2023ACC: 0001104659-23-074784
-34.85K
Net shares
Net seller
$814.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
34.85K disposed
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
−34.85K
Price / share
$23.37
Trade value
$814.54K
% of position
27.1%
6/23/2023
128.73K→93.88K
Total
Net shares
−34.85K
Net value
-$814.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 6/23/2023 | S · Sale | −34.85K | $23.37 | $814.54K | 27.1% | 128.73K | 93.88K |
| Total | −34.85K | -$814.54K | ||||||
Derivative Transactions0
No derivative transactions reported